An image of a person looking at a financial report
Markets

Advisory Board Company Sees IBD RS Rating Climb To 72

An image of a person looking at a financial report
Shutterstock photo

On Tuesday, Advisory Board Company ( ABCO ) earned a positive adjustment to its Relative Strength ( RS ) Rating , from 69 to 72.

[ibd-display-video id=2385970 width=50 float=left autostart=true] IBD's unique RS Rating measures market leadership by using a 1 (worst) to 99 (best) score that identifies how a stock's price performance over the trailing 52 weeks matched up against all other stocks.

Decades of market research reveals that the market's biggest winners typically have an RS Rating north of 80 as they begin their biggest price moves. See if Advisory Board Company can continue to show renewed price strength and hit that benchmark.

Looking For Winning Stocks? Try This Simple Routine

Advisory Board Company is building a consolidation with a 59.60 buy point . See if it can break out in heavy volume.

Earnings growth decreased in the most recent report from 7% to -20%. But revenue moved higher, from -3% to 1%.

The company holds the No. 6 rank among its peers in the Commercial Services-Healthcare industry group. National Research ( NRCIA ), Healthcare Services ( HCSG ) and Corvel ( CRVL ) are among the top 5 highly rated stocks within the group.

RELATED:

IBD Stock Rating Upgrades: Rising Relative Strength

Why Should You Use IBD's Relative Strength Rating?

How Relative Strength Line Can Help You Judge A Stock

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

CRVL RS HCSG

Other Topics

Stocks